Answers are grounded in this paper and cite their sources.
Systemic lupus erythematosus is a chronic autoimmune disease characterized by remitting and relapsing systemic symptoms, and circulating antibodies (anti-ds DNA, anti-Smith and anti-phospholipid antibodies). Multiple cases exist in patients who have developed severe cutaneous drug reactions, prompt medical dermatological treatment may alleviate the severity of this clinical manifestation. Individuals with underlying chronic autoimmune disease are two times more likely to develop these drug reactions due to triggering circulating antibodies and worsening their clinically complex condition by use of immunosuppressants. Sulfonamide antibiotics are essential pharmacological agents used in the treatment of a variety of clinical conditions in medicine. In combination with Trimethoprim, they are used to provide a synergistic effect. Sulfonamides work by interfering with the production of folic acid in bacteria, which is essential for nucleic acid formation and DNA and RNA. Trimethoprim is an antibiotic that works by inhibiting bacterial dihydrofolate reductase, an enzyme essential for the conversion of dihydrofolate to tetrahydrofolate, the active form of folic acid. Patients with sulfonamide allergies may develop Steven-Johnson syndrome, hemolytic anemia, thrombocytopenia, agranulocytosis, urticaria, acute interstitial nephritis, and photosensitivity. Steven-Johnson syndrome is an inflammatory reaction caused by type IV hypersensitivity reaction; effector CD4+ T cells recognize antigen and release inflammation-inducing cytokines.
No takes yet. Share an insight, caveat, or question.
Odeyinka et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: